![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Sponsored by: |
M.D. Anderson Cancer Center |
---|---|
Information provided by: | M.D. Anderson Cancer Center |
ClinicalTrials.gov Identifier: | NCT00532064 |
Primary Objective:
Secondary Objective:
Condition | Intervention |
---|---|
Advanced Cancers |
Behavioral: Questionnaire |
Study Type: | Observational |
Study Design: | Case-Only, Prospective |
Official Title: | Early Detection of Cardiotoxicity During Sunitinib or Sorafenib Chemotherapy Using Cardiac Biomarkers |
During the standard-of-care blood draws, additional blood will be drawn to test troponin I and/or T and BNP levels.
Estimated Enrollment: | 200 |
Study Start Date: | September 2007 |
Estimated Primary Completion Date: | December 2009 (Final data collection date for primary outcome measure) |
Groups/Cohorts | Assigned Interventions |
---|---|
1
Patients with advanced cancer receiving sunitinib malate or sorafenib chemotherapy.
|
Behavioral: Questionnaire
Symptom questionnaire taking about 10-15 minutes.
|
Ages Eligible for Study: | 18 Years to 85 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Patients with advanced cancer receiving sunitinib malate or sorafenib chemotherapy.
Inclusion Criteria:
Exclusion Criteria:
Contact: Daniel J. Lenihan, MD | 713-794-4197 |
United States, Texas | |
U.T.M.D. Anderson Cancer Center | Recruiting |
Houston, Texas, United States, 77030 | |
Principal Investigator: Daniel J. Lenihan, MD |
Principal Investigator: | Daniel J. Lenihan, MD | U.T.M.D. Anderson Cancer Center |
Responsible Party: | U.T.M.D. Anderson Cancer Center ( Daniel J. Lenihan, MD/Associate Professor ) |
Study ID Numbers: | 2006-0921 |
Study First Received: | September 18, 2007 |
Last Updated: | December 30, 2008 |
ClinicalTrials.gov Identifier: | NCT00532064 History of Changes |
Health Authority: | United States: Institutional Review Board |
Advanced Cancers Cardiotoxicity Detection Heart Damage Troponin 1 Blood Test |
B-type Natriuretic Peptide Blood Test Questionnaire Survey BNP |
Natriuretic Peptide, Brain Sunitinib Sorafenib |